BMIPP imaging to improve the value of sestamibi scintigraphy for predicting functional outcome in severe chronic ischemic left ventricular dysfunction

Journal of Nuclear Medicine

Volumn 40, Issue 9, 1999, Pages 1468-1476

  Hambye, Anne Sophie E ^a   Dobbeleir, André A ^b   Vervaet, Ann M ^b   Van Den Heuvel, Paul A ^b   Franken, Philippe R ^b  

^a MIDDELHEIM HOSPITAL   (Belgium)

^b NONE

Author keywords

BMIPP; Chronic left ventricular dysfunction; Ejection fraction; Functional recovery; Myocardial viability

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE INFARCTION; HUMAN; MALE; PRIORITY JOURNAL; SCINTIGRAPHY;

EID: 0032875644     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Elefteriades JA, Tolis G, Levi E, Mills LK, Zaret BL. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol. 1993;22:1411-1417.
2. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med. 1986;341:884-888.
3. Opie LH. Metabolism of heart in health and disease. Part I. Am J Heart. 1968;76:685-698.
4. Knapp FF Jr, Ambrose KR, Goodman MM. New radioiodinated methyl-branched fatty acids for cardiac studies. Eur J Nucl Med. 1986;12(suppl):S39-S44.
5. Yamamichi Y, Kusuoka H, Morishita K, et al. Metabolism of iodine-123-BMIPP in perfused rat hearts. J Nucl Med. 1995;36:1043-1050.
6. Franken PR, Dendale P, De Geeter F, Demoor D, Bossuyt A, Block P. Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy. J Nucl Med. 1996;37:718-722.
7. Sloof GW, Visser FC, Bax JJ, et al. Increased uptake of iodine-123-BMIPP in chronic ischemic heart disease: comparison with fluorine-18-FDG SPECT. J Nucl Med. 1998;39:255-260.
8. Tamaki N, Tadamura E, Kudoh T, et al. Prognostic value of iodine-123-labelled BMIPP fatty acid analogue in patients with myocardial infarction. Eur J Nucl Med. 1996;23:272-279.
9. 99mTc RBC for equilibrium ventriculography. J Nucl Med. 1997;38:1521-1528.
10. Hambye AS, Dobbeleir A, Vervaet A, Chi-Chou H. Can we rely on technetium-99m-sestamibi gated tomographic myocardial perfusion imaging to quantify left ventricular function? A comparative study with classical isotopic techniques for ejection fraction measurement. Nucl Med Commun. 1997;18:751-760.
11. Hambye AS, Vaerenberg M, Dobbeleir A, Van den Heuvel P, Franken PR. Abnormal BMIPP uptake in chronically dysfunctional myocardial segments: correlation with contractile response to low dose dobutamine. J Nucl Med. 1998;39:1845-1850.
12. 99mTc-sestamibi. Circulation. 1994;89:2552-2561.
13. 123I-β-methyl-iodo-phenyl pentadecanoic acid. Eur J Nucl Med. 1994;21:283-291.
14. White HD, Norris RM, Brown MA, Brandt PWT, Whitlock RML, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987;76:44-51.
15. Bonow RO. Prognostic assessment in coronary artery disease: role of radionuclide angiography. J Nucl Cardiol. 1994;1:280-291.
16. Hanley JA, McNeill BJ. A method comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839-843.
17. Fujibayashi Y, Yonekura Y, Takemura Y, et al. Myocardial accumulation of iodinated beta-methyl branched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S) methyl pentadecanoic acid (BMIPP) in relation to ATP concentration. J Nucl Med. 1990;31:1818-1822.
18. Tamaki N, Tadamura M, Kawamoto M, et al. Decreased uptake of iodinated branched fatty acid analog indicates metabolic alterations in ischemic myocardium. J Nucl Med. 1995;36:1974-1980.
19. Tamaki N, Kawamoto M, Yonekura Y, et al. Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: assessment with emission tomography using an iodinated branched fatty acid analog. J Nucl Med. 1992;33:659-667.
20. Altehoefer C, vom Dahl J, Biedermann M, et al. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET. J Nucl Med. 1994;35:569-574.
21. 201Tl to myocardial blood flow in a canine model of myocardial ischemic insult. Circulation. 1990;81:289-296.
22. 18F-fluorodeoxyglucose. Circulation. 1994;89:578-587.
23. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol. 1997;30:1451-1460.
24. Yoshida S, Ito M, Mitsnami K, Kinoshita M. Improved myocardial fatty acid metabolism after coronary angioplasty in chronic coronary artery disease. J Nucl Med. 1998;39:933-938.
25. Borgers M. Pathologic findings in chronic hibernating myocardium. In: Heyndrickx GR, Vatner SF, Wijns W, eds. Stunning, Hibernation and Preconditioning. Philadelphia, PA: Lippincott-Raven; 1997:287-306.